Phenotypic variability in childhood TB: Implications for diagnostic endpoints in tuberculosis vaccine trials.

Mulenga H, Moyo S, Workman L, Hawkridge T, Verver S, Tameris M, Geldenhuys H, Hanekom W, Mahomed H, Hussey G, Hatherill M.

Vaccine 2011;29(26):4316-21.

Abstract http://www.ncbi.nlm.nih.gov/pubmed/21527304